Related Experiment Video
Updated: Aug 26, 2026

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells
Den-En Shieh1, Yuan-Ying Chen, Ming-Hong Yen
1Graduate Institute of Pharmaceutical Sciences, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
Abstract:
Most of the commonly used cytotoxic anticancer drugs have been shown to induce apoptosis in susceptible cells. However, the signaling pathway of their apoptotic effects remains undefined. In this study, the cytotoxic effect of emodin on various human hepatoma cell lines was investigated. Results demonstrated that emodin exhibited strongly suppressing effect on HepG2/C3A, PLC/PRF/5, and SK-HEP-1 cells, with the IC(50) value of 42.5, 46.6, and 53.1 microM, respectively. Furthermore, emodin induced apoptosis in HepG2/C3A cells was clearly verified by the appearance of DNA fragmentation and sub-G(1) accumulation. Besides, HepG2/C3A cells were found to be arrested in G(2)/M phase after the cells were treated with 60 microM emodin for 48 h. Moreover, significant increase in the levels of apoptosis-related signals such as p53 (419.3 pg/ml), p21 (437.4 units/ml), Fas (6.6 units/ml), and caspase-3 (35.4 pmol/min) were observed in emodin treated HepG2/C3A cells. Taken together, emodin displays effective inhibitory effects on the growth of various human hepatoma cell lines and stimulates the expression of p53 and p21 that resulted in the cell cycle arrest of HepG2/C3A cells at G(2)/M phase. Results also suggest that emodin-induced apoptosis in HepG2/C3A cells were mediated through the activation of p53, p21, Fas/APO-1, and caspase-3. It implies that emodin could be a useful chemotherapeutical agent for treatment of hepatocellular carcinoma (HCC).
Insights
Emodin effectively inhibits human hepatoma cell growth by inducing apoptosis and cell cycle arrest. This natural compound activates key signaling pathways, suggesting its potential as a hepatocellular carcinoma (HCC) therapeutic agent.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Cytotoxic anticancer drugs often induce apoptosis, but their signaling pathways are not fully understood.
- Hepatocellular carcinoma (HCC) remains a significant health concern, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the cytotoxic effects of emodin on human hepatoma cell lines.
- To elucidate the underlying molecular mechanisms of emodin-induced apoptosis and cell cycle arrest.
Main Methods:
- Assessing emodin's cytotoxic effect using IC(50) values on HepG2/C3A, PLC/PRF/5, and SK-HEP-1 cells.
- Analyzing DNA fragmentation and sub-G(1) cell cycle accumulation to confirm apoptosis.
- Evaluating cell cycle progression and expression of apoptosis-related proteins (p53, p21, Fas, caspase-3).
Main Results:
- Emodin demonstrated significant inhibitory effects on hepatoma cell lines with determined IC(50) values.
- Apoptosis was confirmed in HepG2/C3A cells via DNA fragmentation and sub-G(1) phase accumulation.
- Emodin treatment led to G(2)/M phase cell cycle arrest and increased levels of p53, p21, Fas, and caspase-3.
Conclusions:
- Emodin effectively inhibits human hepatoma cell growth and induces apoptosis.
- The mechanism involves p53 and p21 activation, leading to G(2)/M cell cycle arrest.
- Emodin shows promise as a chemotherapeutic agent for hepatocellular carcinoma (HCC).
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
